Skip to Content

Tom Tillett

Tom	Tillett

Tom Tillett

Founder & CEO

MBF Therapeutics

Thomas Tillett is co-founder and CEO of MBF Therapeutics, an animal health biotech company developing innovative immunotherapies to treat companion animals. He was founder, president and CEO of RHeoGene LLC, which established an innovative clinical development program with the RheoSwitch® Therapeutic System that led to the first human clinical trial of a small molecule-induced gene regulation system. He is founder and executive director of Sustained Acts, a Christian nonprofit focusing on sustainable projects in Africa.

Conference Location

201 N 17th St.
Philadelphia, PA 19103
Tel: (215) 448-2000